The Abdominal Image-Guided Interventions Laboratory is a multi-modality laboratory that is engaged in cutting-edge research involving interventional strategies for the minimally- or non-invasive treatment of a variety of benign and malignant diseases. We also study imaging solutions, particularly those that have high potential to guide, monitor and assess image-guided interventions.

Our multidisciplinary team draws from radiology, medical physics, engineering, surgery, urology, and statistics in projects that take on some of the most difficult problems in human health. We research minimally or non-invasive image-guided treatments for cancer such as radiofrequency ablation, microwave ablation, cryoablation, and histotripsy. In medical imaging, we are actively engaged in research on CT fluoroscopy, cone-beam CT, and ultrasound fusion techniques to guide interventions. Most of our projects are translational in nature, and we are highly focused on moving our discoveries from the laboratory to human clinical use. To do this, we collaborate with the NIH and FDA as well as industry partners such as Johnson and Johnson, Medtronic, Histosonics, and Elucent Medical.

Our lab is the birthplace of many medical discoveries and devices, as well as two venture-backed startup companies (NeuWave Medical, Madison WI, sold to Johnson & Johnson/Ethicon in 2016) and Elucent Medical, Inc. based in Minneapolis, MN.